A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...] …
Year: 2024
Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...] …
More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect
Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...] …
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...] …
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...] …
SPONSORED CONTENT
Artificial Intelligence (AI) is making significant strides in healthcare, and its potential impact on the 340B Drug Pricing Program is becoming increasingly evident.
What can AI do for 340B?
AI offers
…
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...] …
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...] …
SPONSORED CONTENT
In the complex landscape of healthcare, compliance with the Health Resources and Services Administration’s (HRSA) 340B program is paramount for covered entities. As organizations strive to optimize their participation in the program, one critical aspect is preparing for HRSA audits. To shed light on this crucial process, we
…